About Leanbio
Leanbio is a company based in Barcelona (Spain) founded in 2014 was acquired by Laboratorio Reig Jofre in December 2025.. Leanbio has raised $6.28 million across 2 funding rounds from investors including Laboratorio Reig Jofre and European Union. Leanbio offers products and services including Tech Transfer, Cell Line Development, Process Development, Analytical Development, and cGMP Manufacturing. Leanbio operates in a competitive market with competitors including KBI Biopharma, EirGenix, Aldevron, Arranta Bio and Ovagen, among others.
- Headquarter Barcelona, Spain
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Leanbio S.L.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$6.28 M (USD)
in 2 rounds
-
Latest Funding Round
$6.28 M (USD), Angel Round
Apr 08, 2024
-
Investors
Laboratorio Reig Jofre
& 1 more
-
Employee Count
Employee Count
-
Acquired by
Laboratorio Reig Jofre
(Dec 02, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Leanbio
Leanbio offers a comprehensive portfolio of products and services, including Tech Transfer, Cell Line Development, Process Development, Analytical Development, and cGMP Manufacturing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Facilitates transfer of biopharmaceutical technologies for efficient production
Develops cell lines for biopharmaceutical manufacturing and research
Optimizes processes for biopharmaceutical production and validation
Provides testing and analysis for biopharmaceutical product quality
Conducts compliant manufacturing for preclinical and clinical biologics
Unlock access to complete
Sales and Marketing
1 people
Leadership Team
1 people
Software Development Team
1 people
MSAT Team
1 people
Unlock access to complete
Funding Insights of Leanbio
Leanbio has successfully raised a total of $6.28M across 2 strategic funding rounds. The most recent funding activity was a Angel Round round of $6.28 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Angel Round — $6.3M
-
First Round
First Round
(01 Mar 2021)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2024 | Amount | Angel Round - Leanbio | Valuation |
investors |
|
| Mar, 2021 | Amount | Grant - Leanbio | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Leanbio
Leanbio has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Laboratorio Reig Jofre and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location | |
|
Pharmaceutical products and food supplements are manufactured and marketed globally.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Leanbio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Leanbio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Leanbio Comparisons
Competitors of Leanbio
Leanbio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as KBI Biopharma, EirGenix, Aldevron, Arranta Bio and Ovagen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of protein formulation, process & cell line development, and cGMP services
|
|
| domain | founded_year | HQ Location |
Biologics development and manufacturing services are offered by EirGenix.
|
|
| domain | founded_year | HQ Location |
Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for microbiome based diseases
|
|
| domain | founded_year | HQ Location |
Provider of germ-free and specific pathogen free production of eggs for vaccine and antibody manufacturing services
|
|
| domain | founded_year | HQ Location |
Vaccines and biologics are developed and manufactured by IDT Biologika.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Leanbio
Frequently Asked Questions about Leanbio
When was Leanbio founded?
Leanbio was founded in 2014 and raised its 1st funding round 7 years after it was founded.
Where is Leanbio located?
Leanbio is headquartered in Barcelona, Spain. It is registered at Barcelona, Catalonia, Spain.
Who is the current CEO of Leanbio?
Andreu Soldevila is the current CEO of Leanbio.
Is Leanbio a funded company?
Leanbio is a funded company, having raised a total of $6.28M across 2 funding rounds to date. The company's 1st funding round was a Grant of $1.68M, raised on Mar 01, 2021.
What does Leanbio do?
Founded in 2014 in Barcelona, Spain, Leanbio operates in the biopharmaceutical sector with a focus on immunotherapy. Recombinant proteins are developed using expression systems such as E. coli, CHO mammalian cell lines, P. pastoris, and S. cerevisiae. Platforms for upstream and downstream processing of microbial and mammalian cell cultures are utilized, along with purification methods for biotherapeutics. Analysis and formulation of protein therapeutics are also supported through established platforms.
Who are the top competitors of Leanbio?
Leanbio's top competitors include KBI Biopharma, Aldevron and Ovagen.
What products or services does Leanbio offer?
Leanbio offers Tech Transfer, Cell Line Development, Process Development, Analytical Development, and cGMP Manufacturing.
Who are Leanbio's investors?
Leanbio has 2 investors. Key investors include Laboratorio Reig Jofre, and European Union.